Evaluation of Digiphysical Screening for Familial Hypercholesterolemia - Efficacy of Digiphysical Screening, Effects on Cardiovascular Morbidity and Mortality and Health Economic Aspects

Status: Enrolling_by_invitation
Location: See location...
Study Type: Observational
SUMMARY

Longitudinal and observational registry-based cohort study of individuals participating in the national digiphysical screening program for Familial Hypercholesterolemia. The information collected in the screening process will be combined in pseudo-anonymous form with data from the National Board of Health and Welfare (registries: Cause of Death, Diagnoses according to International Classification of Diseases (ICD) and Prescribed drugs) and Statistic Sweden (Longitudinal integrated database for health insurance and labour market studies). Primary analysis: association between Familial Hypercholesterolemia and cardiovascular disease. Secondary analysis: efficacy and health economic aspects of digiphysical screening for Familial Hypercholesterolemia.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Swedish personal identification number

Locations
Other Locations
Sweden
Karolinska university hospital
Stockholm
Time Frame
Start Date: 2021-09-01
Completion Date: 2033-09
Participants
Target number of participants: 30000
Treatments
Individuals screened for Familial Hypercholesterolemia
Individuals participating in diagnostic activities in the digiphysical health care screening program for Familial Hypercholesterolemia and have provided informed consent are included in the cohort.
Sponsors
Leads: Karolinska Institutet

This content was sourced from clinicaltrials.gov